EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 4.0

A Population‐Based Nomogram for Predicting Overall Survival in Pulmonary Sarcomatoid Carcinoma With Real‐World External Validation

Shuwen Cui iD, Yimeng Li, Xiaoyu Zhang iD, Yuanyuan Fan, Kaidiriye Setiwalidi, Yingming Zhang, Huan Gao, Xiaoqiang Zheng, Zhiping Ruan iD, Chunli Li iD, Xuan Liang, Tao Tian und 2 weitere

Cancer Medicine · 2026-05 · 15 (5)

DOI: 10.1002/cam4.71945 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Cancer Medicine, online erschienen am 19.05.2026. Verfasst von Shuwen Cui und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, People's Republic of China. Hauptthemen laut MEDLINE: Nomograms, Lung Neoplasms, Carcinosarcoma. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shaanxi Administration of Traditional Chinese Medicine, the Foundations of the First Affiliated Hospital of Xi'an Jiaotong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary sarcomatoid carcinoma (PSC) is a rare and highly aggressive tumor. This study aimed to investigate the prognostic factors of PSC and develop a new risk classifier to predict patients' overall survival (OS).

Methods

This retrospective study consisted of 675 PSC patients registered in the Surveillance, Epidemiology, and End Results (SEER) database, and 90 patients from the First Affiliated Hospital of Xi'an Jiaotong University. The univariate and multivariate Cox regression analyses were adopted to select the best prognostic variables. A nomogram was developed to predict the OS of these patients. The nomogram was assessed using receiver operating characteristic (ROC) curves, the concordance index (C‐index), and calibration curves. Decision curve analysis (DCA) was adopted to assess its net clinical benefit. Additionally, a Lasso‐Cox regression model was utilized to explore prognostic factors in real‐world patients with PSC.

Results

The multivariate analysis revealed that sex, T, N, and M stages, surgery, radiation, chemotherapy, and liver metastasis were independent prognostic factors of OS for patients with PSC, and a nomogram was developed to predict the OS of these patients. The ROC curves and the estimated C‐index displayed that the nomogram yielded excellent performance in predicting OS. Calibration curves demonstrated satisfactory consistency between the actual and predicted OS. DCA illustrated that the nomogram would provide significant net clinical benefits. Consistent findings were discovered in the internal and external validation cohorts. Lasso‐Cox regression models revealed that surgery and immunotherapy were key protective factors for OS, while ECOG ≥ 2, underlying medical history, and distant metastasis constituted major risk factors for OS.

Conclusions

The constructed nomogram is a reliable risk classifier to achieve personalized survival probability prediction for patients with PSC. Real‐world data suggest that immunotherapy is associated with significantly prolonged survival in patients with PSC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NomogramsLung NeoplasmsCarcinosarcomaHumansFemaleMalePrognosisRetrospective StudiesMiddle AgedSEER ProgramROC CurveAgedAdultRisk Factors

Stichwörter der Autor:innen

antiangiogenic drugsimmune checkpoint inhibitors (ICIs)nomogramoverall survival (OS)prognostic factorpulmonary sarcomatoid carcinoma (PSC)

Autor:innen und Institutionen

  • Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, People's Republic of China.

ORCID-Profile: Shuwen Cui, Xiaoyu Zhang, Zhiping Ruan, Chunli Li, Yu Yao

Förderung

  • Shaanxi Administration of Traditional Chinese Medicine
  • the Foundations of the First Affiliated Hospital of Xi'an Jiaotong University

Zitieren

APA

Cui, S., Li, Y., Zhang, X., Fan, Y., Setiwalidi, K., Zhang, Y., Gao, H., Zheng, X., Ruan, Z., Li, C., Liang, X., Tian, T., Yao, Y., & Fu, X. (2026). A Population‐Based Nomogram for Predicting Overall Survival in Pulmonary Sarcomatoid Carcinoma With Real‐World External Validation. Cancer Medicine, 15(5). https://doi.org/10.1002/cam4.71945

Vancouver

Cui S, Li Y, Zhang X, Fan Y, Setiwalidi K, Zhang Y, et al. A Population‐Based Nomogram for Predicting Overall Survival in Pulmonary Sarcomatoid Carcinoma With Real‐World External Validation. Cancer Medicine. 2026;15(5). doi:10.1002/cam4.71945

BibTeX
@article{Cui2026,
  author = {Cui, Shuwen and Li, Yimeng and Zhang, Xiaoyu and Fan, Yuanyuan and Setiwalidi, Kaidiriye and Zhang, Yingming and Gao, Huan and Zheng, Xiaoqiang and Ruan, Zhiping and Li, Chunli and Liang, Xuan and Tian, Tao and Yao, Yu and Fu, Xiao},
  title = {A Population‐Based Nomogram for Predicting Overall Survival in Pulmonary Sarcomatoid Carcinoma With Real‐World External Validation},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {5},
  doi = {10.1002/cam4.71945}
}
Kostenlos starten →